1. Home
  2. EXEL vs YPF Comparison

EXEL vs YPF Comparison

Compare EXEL & YPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • YPF
  • Stock Information
  • Founded
  • EXEL 1994
  • YPF 1977
  • Country
  • EXEL United States
  • YPF Argentina
  • Employees
  • EXEL N/A
  • YPF N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • YPF Integrated oil Companies
  • Sector
  • EXEL Health Care
  • YPF Energy
  • Exchange
  • EXEL Nasdaq
  • YPF Nasdaq
  • Market Cap
  • EXEL 11.3B
  • YPF 13.3B
  • IPO Year
  • EXEL 2000
  • YPF 1993
  • Fundamental
  • Price
  • EXEL $44.08
  • YPF $33.13
  • Analyst Decision
  • EXEL Buy
  • YPF Buy
  • Analyst Count
  • EXEL 18
  • YPF 7
  • Target Price
  • EXEL $43.00
  • YPF $41.30
  • AVG Volume (30 Days)
  • EXEL 3.3M
  • YPF 1.6M
  • Earning Date
  • EXEL 08-05-2025
  • YPF 08-08-2025
  • Dividend Yield
  • EXEL N/A
  • YPF N/A
  • EPS Growth
  • EXEL 237.58
  • YPF N/A
  • EPS
  • EXEL 2.20
  • YPF 3.61
  • Revenue
  • EXEL $2,298,922,000.00
  • YPF $17,858,226,821.00
  • Revenue This Year
  • EXEL $9.37
  • YPF $19.30
  • Revenue Next Year
  • EXEL $11.05
  • YPF N/A
  • P/E Ratio
  • EXEL $19.98
  • YPF $9.37
  • Revenue Growth
  • EXEL 24.49
  • YPF 131.82
  • 52 Week Low
  • EXEL $21.82
  • YPF $16.18
  • 52 Week High
  • EXEL $49.62
  • YPF $47.43
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 57.96
  • YPF 42.72
  • Support Level
  • EXEL $42.66
  • YPF $32.87
  • Resistance Level
  • EXEL $49.62
  • YPF $36.34
  • Average True Range (ATR)
  • EXEL 1.58
  • YPF 1.36
  • MACD
  • EXEL 0.10
  • YPF -0.33
  • Stochastic Oscillator
  • EXEL 43.24
  • YPF 11.79

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About YPF YPF Sociedad Anonima

YPF SA is an Argentina-based integrated oil and gas company. It is engaged in operating a fully integrated oil and gas chain across the domestic upstream, downstream, and gas and power segments. Its upstream segment consists of exploration, development, and production of crude oil, natural gas, and LPG. Its downstream segment include refining, marketing, transportation, and distribution of oil and a wide range of petroleum products, petroleum derivatives, petrochemicals, LPG and bio-fuels. Gas and Power segment performs activities related to natural gas transportation to third parties and Downstream segment. Central Administration and Others includes activities performed by the Group not falling under the business segments. It generates maximum revenue from downstream segment.

Share on Social Networks: